Tag Archives: Ed Markey
Dear Research Advocate,
The President’s budget is out and it’s a mixed bag. First, the good news. NSF was given a significant funding boost, $593M over 2012 levels, NIH funding was increased by $470M, and AHRQ, via budget trade-offs, looks to have been boosted by $64M. The increases are from FY12 to FY14, since the President’s budget replaces sequestration in a different way than either Congressional body (see more below). The not so good news in the President’s budget is that other health research agencies did not fare well. The CDC budget was cut deeply, especially prevention programs. FDA was essentially flat -funded. And entitlement-reform may pose a challenge to innovation.
The different ways the three budgets, President, Senate and House, deal with sequestration is symptomatic of the continuing failure to reach agreement on anything resembling comprehensive legislation, including so-called “grand bargains.” The fact that there is so much attention to medical research in the President’s budget, as well as on the floor of the Senate recently, and from a number of Members of Congress, speaks to the progress the research advocacy community is making in bringing medical research to the forefront. But success to date has not diminished the need for heightened advocacy for public health and social sciences research, nor the imperative of carefully evaluating the full consequences of changes to entitlements. The three budgets deal with entitlements in different ways, but with similar ill-effect when it comes to innovation. There is no question that we need tax and entitlement reform, and no question that sequestration must be eliminated; however, we cannot thrive as a nation or succeed at deficit reduction if entitlement reforms come at the expense of private sector innovation. See our statement on the President’s budget here.
Speaking of social science research — so clearly under fire — it is not too late to RSVP to a Capitol Hill briefing we are co-hosting tomorrow on economic research. There is a terrific lineup of speakers.
I know many of you attended the Rally for Medical Research on Monday here in Washington, a coalition effort led by the AACR. Thousands of like-minded research advocates and a wonderful array of speakers, including our board chair, The Honorable John Porter, gathered to crank up the volume for research. In his remarks, Mr. Porter urged advocates to get fighting mad or we risk continued cuts from Congress. Review his remarks here; then, take a moment to participate in the Rally’s on-going text messaging campaign to urge Congress to assign a high priority to medical research. You can view press coverage of the event and the full list of speakers. During the event, social media attention was strong — messaging trended #2 globally on Twitter. That’s the level of volume and attention we must continue to maintain if we want to see a happy ending to budget negotiations. Please do your part!
More than 50 Nobel laureates are doing their part; they have joined forces to send a letter to Congress urging them to fund, rather than freeze or cut, research and development. In the letter, the Laureates cite their deep concern over reduced funding levels and the negative impact this will have on the next generation of scientists and ultimately, upon our nation’s economic vitality. It’s a good reminder that the full science community is in this battle together. Take a moment now to echo their message by urging your representative to sign on the Markey-McKinley letter calling for a $1.5B boost to NIH funding. Click here to see the list of current signers. If your representative is on the list, be sure to thank them for standing up for research. If they haven’t signed-on yet, click here to send them a message.
On Monday, we released our latest national poll, focused on chronic pain and drug addiction. Surprisingly, only 18% of the poll respondents believe chronic pain is a major health problem, yet two-thirds know someone who has sought relief from chronic pain. Huge majorities are concerned about abuse or misuse of prescription medications; the need for better understanding of how to address chronic pain literally cries out for research. You can view our media release here.
Dear Research Advocate,
Glimmers of hope can be found in the dire funding situation we face under sequestration. The continuing resolution (C.R.) funding the government through the end of the fiscal year (September 30) included very small increases for NIH, CDC, NSF and FDA; AHRQ was flat funded. But the fact remains that these increases were overwhelmed by the effect of sequestration, which remains in place and will continue to weigh us down for 10 years unless overturned. Our champions in Congress are speaking out and taking a stand on behalf of research as the budget negotiation proceeds. Reps. McKinley (R-WV) and Markey (D-MA) have co-authored a letter to House appropriators calling for $32 billion for NIH in FY14, a $1.5 billion increase. Take action right away and urge your representatives to sign on! Rep. Steve Cohen (D-TN) delivered a powerful floor speech highlighting the bipartisan importance of investing in NIH. In the Senate, Sens. Durbin, Mikulski, Moran and Cardin sponsored an amendment to the budget resolution calling for increased investment for biomedical research at the NIH. While this move is largely symbolic, it demonstrates the level of bipartisan commitment of our champions. You can view Senator Durbin’s statement here as well as the Research!America statement. And special thanks are due to Senator Harkin for his effort to provide NIH with a $244 million increase as part of the C.R. His sustained leadership has helped in so many ways to sustain NIH through good times and bad. Read our statement on his amendment here.
Congress is on recess and getting an earful from their constituents. A new public opinion poll shows that people are extremely angry at Congress but don’t see that sequestration is going to be a problem. That’s why it’s important to connect the dots. Hooray for a flurry of articles published in newspapers in Baltimore, Lancaster (PA), Los Angeles and Seattle —all emphasizing the damage being done by sequestration. More are called for! In a pulling-no-punches editorial in Science, Dr. Bruce Alberts lays out his concerns for the future of research, a future that is closely linked to the decisions our elected officials will make over the coming months. He invites responses; you can weigh in.
Many of you may be aware of our upcoming panel discussion on April 8 — Conquering Pain & Fighting Addiction: Policy Imperatives to Combat a Growing Health Crisis — featuring thought leaders on issues relating to pain and addiction. This a critical topic of growing national importance with a major role for research — I hope you can join us. Register here. Earlier in the day, the entire staff of Research!America will join tens of thousands of advocates at the Rally for Medical Research on the steps of the Carnegie Library in Washington, DC. Let’s all join forces that day to drive home the message that research must be a higher national priority.
A Weekly Advocacy Message from Mary Woolley: New Poll – Likely Voters Say to Congress: Stay in Session, Avoid Taking Us Over the Fiscal Cliff
Dear Research Advocate,
To call attention to the unintended consequences of the sequester, we held a press briefing today in partnership with United for Medical Research. Two Members of Congress who are still in town, Reps. Ed Markey (D-MA) and Brian Bilbray (R-CA), spoke about the high priority the nation must place on NIH and about the usefulness of data from a new national public opinion poll showing that 51% of Americans say that across-the-board cuts are not the right way to reduce the deficit. To see more poll results for use in your advocacy, click here. Other speakers this morning spoke about what’s at stake for everyone who cares about the research enterprise: patient hopes for cures delayed; industries unable to create new jobs and drive innovation in frustration about U.S. policies and lack of predictability; young scientists becoming discouraged and accepting offers to work in other countries – countries that have made research a clear priority. All of this further burdens our national deficit – we need research to combat the rising cost of health care by delaying the onset of Alzheimer’s and a host of other diseases. As Rep. Markey said, it will take high energy and coordination to get our message of research as a priority heard during the lame-duck session. You will be hearing more from us about how to assure that happens, but in the meantime, don’t forget that there is an important election going on (see below).
First a quick recap of what sequestration means, according to a new OMB report. Most agencies would be hit with an 8.2% cut – NIH alone would lose $2.5 billion in 2013! It is still unclear what level of discretion agency heads would have in carrying out these cuts. Losses at the CDC would be $464 million, the FDA would lose $318 million, and the NSF would be cut by $577 million. See our new one-pager with the latest data.
There is an additional dimension to the FDA cut that should be of significant concern to all advocates for medical progress. Part of the cut diverts industry-supplied user fees into deficit reduction. Those fees are paid by industry for the express purpose of ensuring FDA has the resources to review new medicines and medical devices on a timely basis. The precedent of playing bait and switch with user fees is a dangerous one, particularly since these fees are voluntary. Why should the drug and device industries agree to pay user fees in the future knowing that still more time will be lost in approvals – and patients will be forced to wait longer for new treatments and cures. We must work together to address it.
We all need to do our part to make sure the media is covering all the aspects of the threat of sequestration, making it more evident to all Americans just what is at stake. We’ve already seen National Journal release an article about our new polling data. The Atlantic released a story about how sequester would impact science budgets, citing another recent article from ScienceInsider. The Scientist also reported on the story, quoting Ellie Dehoney, our VP for policy and programs. This week, the Rochester (MN) Post-Bulletin reported how the cuts at NIH could impact the Mayo Clinic, a Research!America member. For those of you that may have contacts with local or national media, now is the time to let them know about the impact where you live.
We are only a month and half away from the election. We know from many of our members and partners that they are calling/writing/emailing campaigns to urge participation in the Your Candidates –Your Health voter education initiative. Please join the momentum and help drive the campaign … we don’t have much time left to make it clear to candidates that it isn’t only lobbyists and professional advocates (people like us at Research!America) who care about research and want them to talk about it. Every candidate should be hearing from hundreds of concerned stakeholders. Make sure you are in that number!
Demonstrations of the value of NIH and NSF research will soon be honored by Research!America member FASEB. Submit events, exhibits or web-based outreach that highlight the value that research agencies deliver and compete for a cash prize! For details, click here.